site stats

Intensity therapeutics ipo

WebOct 18, 2024 · Intensity Therapeutics, Inc (NASDAQ: INTS) IPO will take place October, 19 on the NASDAQ exchange under the ticker INTS. The company is offering shares at an expected price between $4.00 and $5.00 per share with an insider lock-up period of 180 days ending on April 17, 2024. Intensity Therapeutics, Inc is a clinical-stage biotechnology company ... WebSep 20, 2024 · Intensity Therapeutics, a Phase 2 biotech developing intratumoral injection therapies for cancer, announced new terms for its IPO on Tuesday. The Westport, CT-based company now plans to raise $10 million by offering 2.2 million shares at a …

Intensity Therapeutics, Inc. IPOScoop

WebOct 28, 2024 · Intensity Therapeutics, Inc (NASDAQ: INTS) files IPO registration statement.The company describes itself as: "Intensity Therapeutics, Inc. is a clinical stage biotechnology company passionately ... WebNov 9, 2024 · Intensity Therapeutics, a Phase 2 biotech developing intratumoral injection therapies for cancer, postponed its IPO on Wednesday. It had most recently filed in September to raise $10 million by offering 2.2 million shares at a price range of $4 to $5. makna unity in diversity https://hr-solutionsoftware.com

Intensity Therapeutics, Inc. Common stock - INTS Stock Forecast, Price

WebSep 21, 2024 · Drug delivery developer Intensity Therapeutics ( INTS) has disclosed more terms for a proposed $10M initial public offering. The company said in a filing that it's now considering offering 2.2M... WebSep 20, 2024 · Intensity Therapeutics, Inc (NASDAQ: INTS) has filed for downsized 2,222,223 share IPO at $4-$5 per share. The company previously indicated 1,500,000 share IPO at $9-$11 per share. WebNov 12, 2024 · November 12, 2024. Intensity Therapeutics, a Phase 1 biotech developing intratumoral injection therapies for cancer, announced terms for its IPO on Friday. The Westport, CT-based company plans to raise $15 million by offering 1.5 million shares at a price range of $9 to $11. makna wish you were here

Senior Management Team - Intensity Therapeutics

Category:Clinical Research - Intensity Therapeutics

Tags:Intensity therapeutics ipo

Intensity therapeutics ipo

Solid tumor biotech Intensity Therapeutics removes terms, adds ... - IPOs

WebOct 30, 2024 · Intensity Therapeutics has created an intratumoral therapy for killing solid tumors that also activates systemic immunity. ... (IPO) of $17.25 million worth of its common stock, and has applied to ... WebJan 27, 2024 · Intensity Therapeutics (NASDAQ: INTS) has filed for downsized 1,777,778 share IPO at $4.50 per share. The company previously indicated 2.2M share IPO at $4-$5 per share.

Intensity therapeutics ipo

Did you know?

WebNov 11, 2024 · Intensity Therapeutics, Inc (NASDAQ:INTS) IPO will take place October, 19 on the NASDAQ exchange under the ticker INTS. The company is offering shares at an expected price between $4.00 and $5.00 per share with an insider lock-up period of 180 days ending on April 17, 2024. Web26 rows · Intensity Therapeutics’ new IPO terms, as of Sept. 19, 2024, are: 2.22 million shares ...

WebRenaissance Capital — Solid tumor biotech Intensity Therapeutics sets proposed price at $4.50 ahead of $8 million IPO News • Jan 13, 2024 Renaissance Capital — Solid tumor biotech Intensity Therapeutics lowers share offering by 20% ahead of $8 million IPO Find More Contacts for Intensity Therapeutics Lew Bender CEO, Founder, President

WebApr 14, 2024 · February 14, 2024 finance.yahoo.com Intensity Therapeutics Reports Use of INT230-6 Alone or in Combination with Ipilimumab Shows Evidence of Direct Tumor Necrosis and Promising Overall Survival Results in Adult Subjects with Metastatic Sarcomas at the Connective Tissue Oncology Society (CTOS) 2024 February 14, 2024 … WebOur Story Intensity Therapeutics is a clinical-stage biotechnology company whose mission is to help patients live longer, higher quality lives by discovering, developing, and commercializing first-in-class cancer drugs that attenuate tumors with minimal side effects, while training the patient’s own immune system to fight the cancer. Our lead product …

WebCompany profile for Intensity Therapeutics, Inc. (INTS) with a description, list of executives, contact details and other key facts. ... Intensity Therapeutics will go public soon, but the exact IPO date is still unknown. IPO Price. $4.50. Shares Offered. 1,777,778. Deal Size. $8.00M. Overview;

WebApr 11, 2024 · Upcoming IPO Calendar 👀 See real-time options trading activity and uncover the smart money moves as they happen. Free Week Trial → WhaleStream Learn Education and Resources Dashboard Overview Stock Market Data Top Options Flow (live) Top Dark Pool & Equities Flow (live) Top Options Open Interest Changes Market Tracker Free Daily … makna the moon is beautiful isn\u0027t itWebInvestors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ... makna the scientistWebSep 30, 2024 · Intensity Therapeutics, Inc. has completed an IPO in the amount of $8.1 million. MarketScreener Homepage Equities United States Nasdaq Intensity Therapeutics, Inc. News Summary INTS US45828J1034 INTENSITY THERAPEUTICS, INC. (INTS) Add to my list Summary Quotes News Company Financials Funds Summary Most relevant All … makna the moon is beautiful isn\\u0027t itWebMar 13, 2024 · A far more modest IPO is also in the works courtesy of Intensity Therapeutics, which is offering over 1.7 million shares of common stock at an estimated price of $4.50 apiece. If all goes to plan, the cancer-focused company expects total proceeds of $6.1 million, rising to $7.2 million if underwriters take advantage of the option … makna tarian tor torWebIn 2024, the Company executed a clinical collaboration agreement with Bristol Myers Squibb (BMS) to evaluate the combination of the Company’s lead product, INT230-6, with BMS’s anti-CTLA-4 antibody, Yervoy® (ipilimumab), in patients with advanced sarcoma, breast, and liver cancers. The cohorts are open to enrollment. makna relief candi borobudurWebSep 22, 2024 · Intensity Therapeutics has filed to raise $10 million in an IPO. The firm is developing intratumoral injection treatment approaches for various cancer conditions. Intensity Therapeutics... makna politics as the art of govermentWebWelcome to /r/IPO a subreddit dedicated to news articles and S-1 filings for the newest IPOs. ... Search within r/IPO. r/IPO. Log In Sign Up. User account menu. Found the internet! 2. INTENSITY THERAPEUTICS, INC - S-1 IPO Investment Prospectus. Close. 2. Posted by 15 days ago. INTENSITY THERAPEUTICS, INC - S-1 IPO Investment Prospectus. sec ... makna professional